Format

Send to

Choose Destination
Metab Brain Dis. 2016 Jun;31(3):711-5. doi: 10.1007/s11011-015-9783-9. Epub 2016 Jan 8.

Riluzole rescues alterations in rapid glutamate transients in the hippocampus of rTg4510 mice.

Author information

1
Behavioral Neuroscience, Department of Psychology, West Virginia University, Morgantown, 26506, WV, USA.
2
Drug Discovery & Development Department, School of Pharmacy, Auburn University, 4306 Walker Building, Auburn, AL, 36849, USA.
3
Drug Discovery & Development Department, School of Pharmacy, Auburn University, 4306 Walker Building, Auburn, AL, 36849, USA. reedmir@auburn.edu.

Abstract

Those at risk for Alzheimer's disease (AD) often exhibit hippocampal hyperexcitability in the years preceding diagnosis. Our previous work with the rTg(TauP301L)4510 tau mouse model of AD suggests that this increase in hyperexcitability is likely mediated by an increase in depolarization-evoked glutamate release and a decrease in glutamate uptake, alterations of which correlate with learning and memory deficits. Treatment with riluzole restored glutamate regulation and rescued memory deficits in the TauP301L model. Here, we used enzyme-based ceramic microelectrode array technology to measure real-time phasic glutamate release and uptake events in the hippocampal subregions of TauP301L mice. For the first time, we demonstrate that perturbations in glutamate transients (rapid, spontaneous bursts of glutamate) exist in a tau mouse model of AD mouse model and that riluzole mitigates these alterations. These results help to inform our understanding of how glutamate signaling is altered in the disease process and also suggest that riluzole may serve as a clinically applicable therapeutic approach in AD.

KEYWORDS:

Alzheimer’s disease; Glutamate uptake; Hippocampus; Riluzole; Tau; Tg4510

PMID:
26744018
PMCID:
PMC4864118
DOI:
10.1007/s11011-015-9783-9
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center